Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 21 April 2009
Vol. 2, Issue 67, p. pc8
[DOI: 10.1126/scisignal.267pc8]

PODCASTS

Science Signaling Podcast: 21 April 2009

Michael B. Yaffe1,2 and Annalisa M. VanHook3

1 Chief Scientific Editor of Science Signaling, American Association for the Advancement of Science, 1200 New York Avenue, N.W., Washington, DC 20005, USA.
2 David H. Koch Institute for Integrative Cancer Research, Departments of Biology and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
3 Science Signaling, American Association for the Advancement of Science, 1200 New York Avenue, N.W., Washington, DC 20005, USA.

Abstract: This is a conversation with Michael Yaffe, Chief Scientific Editor of Science Signaling. He discusses signaling through the mammalian target of rapamycin (mTOR) pathway, the topic of a Science Signaling Focus Issue released this week.

Citation: M. B. Yaffe, A. M. VanHook, Science Signaling Podcast: 21 April 2009. Sci. Signal. 2, pc8 (2009).

Read the Full Text



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882